Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy

Por Reau, Nancy, Vekeman, Francis, Wu, Eric, Bao, Yanjun, Gonzalez, Yuri Sanchez
Publicado no Hepatol Commun (2017)

Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines

Por Pyenson, Bruce S., Dieguez, Gabriela, Ferro, Christine, Mavinkurve, Maushumi, Gonzalez, Yuri Sanchez
Publicado no Am Health Drug Benefits (2018)

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

Por Jonas, Maureen M., Squires, Robert H., Rhee, Susan M., Lin, Chih‐Wei, Bessho, Kazuhiko, Feiterna‐Sperling, Cornelia, Hierro, Loreto, Kelly, Deirdre, Ling, Simon C., Strokova, Tatiana, del Valle‐Segarra, Antonio, Lovell, Sandra, Liu, Wei, Ng, Teresa I., Porcalla, Ariel, Gonzalez, Yuri Sanchez, Burroughs, Margaret, Sokal, Etienne
Publicado no Hepatology (2019)